Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KD6001
i
Other names:
KD6001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Shanghai Kanda Biotech
Drug class:
CTLA4 inhibitor
Related drugs:
‹
ipilimumab (223)
tremelimumab (60)
KN046 (19)
cadonilimab (10)
iparomlimab/tuvonralimab (3)
ipilimumab biosimilar (CS1002) (2)
MK-1308 (2)
GI-101 (1)
BNT316 (1)
XTX101 (1)
MEDI5752 (1)
XmAb717 (1)
AI-061 (0)
ATOR-1015 (0)
BMS-986218 (0)
BMS-986249 (0)
BMS-986288 (0)
BT-001 (0)
CD200AR-L (0)
CTLA4 inhibitor (0)
IBI310 (ipilimumab biosimilar) (0)
INV322 (0)
MT-8421 (0)
prolgolimab/nurulimab (0)
ONCR-177 (0)
PF-06753512 (0)
RP2 (0)
RP3 (0)
SAL008 (0)
SHR-8068 (0)
SYN-27M (0)
TG6050 (0)
YH001 (0)
XmAb22841 (0)
SI-B003 (0)
MGD019 (0)
ADG126 (0)
HBM4003 (0)
MK-1308A (0)
ipilimumab (223)
tremelimumab (60)
KN046 (19)
cadonilimab (10)
iparomlimab/tuvonralimab (3)
ipilimumab biosimilar (CS1002) (2)
MK-1308 (2)
GI-101 (1)
BNT316 (1)
XTX101 (1)
MEDI5752 (1)
XmAb717 (1)
AI-061 (0)
ATOR-1015 (0)
BMS-986218 (0)
BMS-986249 (0)
BMS-986288 (0)
BT-001 (0)
CD200AR-L (0)
CTLA4 inhibitor (0)
IBI310 (ipilimumab biosimilar) (0)
INV322 (0)
MT-8421 (0)
prolgolimab/nurulimab (0)
ONCR-177 (0)
PF-06753512 (0)
RP2 (0)
RP3 (0)
SAL008 (0)
SHR-8068 (0)
SYN-27M (0)
TG6050 (0)
YH001 (0)
XmAb22841 (0)
SI-B003 (0)
MGD019 (0)
ADG126 (0)
HBM4003 (0)
MK-1308A (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login